Clinical Trial Update: The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing erythropoietin given at reperfusion in patients with acute myocardial infarction, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Acute Myocardial Infarction | Phase 4 | Status: COMPLETED